Open AccessOsimertinib in the treatment of leptomeningeal disease in T790M-negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report
Author(s) -
Julia Chen,
Hussein Soudy
Publication year - 2019
Publication title -
chinese clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.733
H-Index - 22
eISSN - 2304-3873
pISSN - 2304-3865
DOI - 10.21037/cco.2019.02.02
Subject(s) - osimertinib , t790m , medicine , epidermal growth factor receptor , lung cancer , oncology , tyrosine kinase inhibitor , cancer , cancer research , erlotinib , gefitinib
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom